Search

Your search keyword '"Harry, G.M."' showing total 322 results

Search Constraints

Start Over You searched for: Author "Harry, G.M." Remove constraint Author: "Harry, G.M."
322 results on '"Harry, G.M."'

Search Results

6. Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic FibrosisResearch in context

9. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations

10. Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation

12. ECFS best practice guidelines: the 2018 revision

13. Development and outcomes of a patient driven cystic fibrosis quality of care improvement project

15. Robot-assisted and Fluorescence-guided Remnant-cholecystectomy: A Prospective Dual-Center Cohort Study

16. The influence of exocrine pancreatic function on the exposure and pharmacokinetics of ivacaftor in people with cystic fibrosis

17. Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis

18. Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease

19. Population of Merging Compact Binaries Inferred Using Gravitational Waves through GWTC-3

20. Constraints on the Cosmic Expansion History from GWTC-3

21. Open Data from the Third Observing Run of LIGO, Virgo, KAGRA, and GEO

22. Search for Gravitational Waves Associated with Fast Radio Bursts Detected by CHIME/FRB during the LIGO-Virgo Observing Run O3a

23. Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

25. Breast development in a 7 year old girl with CF treated with ivacaftor: An indication for personalized dosing?

26. Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E–CFTR mutation

27. New Insights in Adherence and Survival in Myotonic Dystrophy Patients Using Home Mechanical Ventilation

28. Search for Gravitational Waves Associated with Gamma-Ray Bursts Detected by Fermi and Swift during the LIGO-Virgo Run O3b

29. Narrowband Searches for Continuous and Long-duration Transient Gravitational Waves from Known Pulsars in the LIGO-Virgo Third Observing Run

30. All-sky search for continuous gravitational waves from isolated neutron stars using Advanced LIGO and Advanced Virgo O3 data

31. Search for intermediate-mass black hole binaries in the third observing run of Advanced LIGO and Advanced Virgo

32. Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis

33. The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial

35. Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline

36. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations

37. sj-docx-1-tar-10.1177_17534666211070143 ��� Supplemental material for Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation

42. Calibration of the LIGO gravitational wave detectors in the fifth science run

43. Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia

44. Prevention of drug-related complications in cystic fibrosis

46. The relation between psychological distress and medication adherence in lung transplant candidates and recipients: A cross-sectional study

47. Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation

48. Fluorescence-Based Quantification of Gastrointestinal Perfusion: A Step Towards an Automated Approach

49. S66 Impact of elexacaftor/tezacaftor/ivacaftor triple combination therapy on health-related quality of life in people with cystic fibrosis homozygous for F508del (F/F): results from a Phase 3 clinical study

50. S65 Impact of elexacaftor/tezacaftor/ivacaftor triple combination therapy on health-related quality of life in people with cystic fibrosis heterozygous for F508del and a minimal function mutation (F/MF): results from a Phase 3 clinical study

Catalog

Books, media, physical & digital resources